文献速递药物不良反应与药物警戒

肿瘤药学服务对化疗所致恶心呕吐管理影响的系统评价与Meta分析

Impact of oncology pharmacy services on the management of chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis.
PubMed 文献 · Am J Health Syst Pharm · 2025-01-01

该系统评价与Meta分析评估临床药师主导的肿瘤药学服务对化疗所致恶心呕吐(CINV)的影响。共纳入12项研究进行系统评价,其中8项进入Meta分析。结果显示药师干预可显著降低恶心和呕吐发生率,且在延迟期效果优于急性期,并改善用药依从性、满意度、生活质量、减少就诊及节约成本。

要点

  • 药师干预显著降低整体治疗期间恶心发生率(OR=1.917,95%CI 1.243-2.955,P=0.003)。
  • 药师干预显著降低整体治疗期间呕吐发生率(OR=2.491,95%CI 1.199-5.177,P=0.014)。
  • 药学服务对CINV控制的效果在延迟期优于急性期。

核心结论

  • 临床药学服务在控制CINV和改善癌症患者整体治疗体验方面具有重要作用。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed、Embase、Cochrane CENTRAL和RISS数据库,共纳入12项研究进行系统评价,其中8项纳入Meta分析。

主要发现

  • 临床药学服务有助于预防和缓解CINV,并改善患者用药依从性、治疗满意度和生活质量,减少就诊次数并节约成本。
  • Meta分析显示,药师干预组整体治疗期间恶心发生率显著低于对照组(OR=1.917,95%CI 1.243-2.955,P=0.003)。
  • Meta分析显示,药师干预组整体治疗期间呕吐发生率显著低于对照组(OR=2.491,95%CI 1.199-5.177,P=0.014)。
  • 临床药学服务对CINV控制的影响在延迟期大于急性期。

临床怎么用

  • 临床药师应参与肿瘤患者CINV管理,以降低恶心呕吐发生率并改善治疗体验。
  • CINV管理中药学服务应特别关注延迟期的预防与控制。

局限性

  • 需要采用标准化的药师服务和结局指标开展进一步研究以验证本研究发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the effect of oncology services rendered by clinical pharmacists on reducing chemotherapy-induced nausea and vomiting (CINV) and improving overall treatment experiences. METHODS: A systematic review and meta-analysis were conducted using studies retrieved from PubMed, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), and Research Information Sharing Service (RISS). The incidence and severity of CINV were evaluated as primary outcomes. Secondary outcomes were patient adherence, patient satisfaction, quality of life (QoL), emergency department (ED) visits, hospitalizations, and costs. RESULTS: A total of 12 studies were selected for systematic review, with 8 studies eligible for meta-analysis. We found that clinical pharmacy services contributed to preventing and alleviating CINV as well as improving patient's medication adherence, treatment satisfaction, and QoL, reducing hospital visits, and achieving cost savings. In the meta-analysis, pharmacists' interventions were notably effective in reducing the incidence of nausea (odds ratio [OR], 1.917; 95% CI, 1.243-2.955; P = 0.003) and vomiting (OR, 2.491; 95% CI, 1.199-5.177; P = 0.014) during overall treatments periods relative to results in control groups. In addition, the impact of clinical pharmacy services on CINV control was greater during the delayed phase compared to the acute phase. CONCLUSION: This study demonstrated the important role of clinical pharmacy services in controlling CINV and enhancing the overall treatment experience for patients with cancer. Further studies with standardized pharmacists' services and outcome measures are needed to validate our findings.

来源:Am J Health Syst Pharm,查看原文。版权归原作者所有。

引用

  1. Shin Y, Shin S, Ryu H, et al. Impact of oncology pharmacy services on the management of chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis. Am J Health Syst Pharm. 2025. PMID: 39196878. doi:10.1093/ajhp/zxae237

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。